Livzon Pharmaceutical Group Inc 2024 SR
The report highlights Livzon Pharmaceutical Group's commitment to innovation in gastroenterology, assisted reproduction, and psychoneurosis. In 2024, the company achieved significant R&D milestones, including US FDA approval for Cetrorelix Acetate for Injection. Livzon prioritized product accessibility, with 191 products included in China's National Medical Insurance Catalogue. Environmental efforts included conducting its first Scope 3 greenhouse gas inventory and maintaining 100% ISO 14001 certification across manufacturing sites. Socially, the company invested RMB 12.98 million in charitable donations and supported over 30,000 people through chronic disease prevention programs.
Company: Livzon Pharmaceutical Group Inc
Sector: Health Care
Country: China
Year: 2024
Type: SR
Pages: 248
Livzon Pharmaceutical Group Inc
ESG Report
The report highlights Livzon Pharmaceutical Group's commitment to innovation in gastroenterology, assisted reproduction, and psychoneurosis. In 2024, the company achieved significant R&D milestones, including US FDA approval for Cetrorelix Acetate for Injection. Livzon prioritized product accessibility, with 191 products included in China's National Medical Insurance Catalogue. Environmental efforts included conducting its first Scope 3 greenhouse gas inventory and maintaining 100% ISO 14001 certification across manufacturing sites. Socially, the company invested RMB 12.98 million in charitable donations and supported over 30,000 people through chronic disease prevention programs.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Apr 23, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees